Je was op zoek naar: mijokardijaka (Maltees - Engels)

mijokardijaka,
heart failure4

iskemija mijokardijaka
myocardial ischaemia

ir-rita mijokardijaka
myocardial wall

+iskemija mijokardijaka, bradikardija
ischaemia, bradycardia

anġina pectoris iskemja mijokardijaka
rare (≥ 1/ 10,000 and < 1/ 1,000)*

iskemija mijokardijaka/infart mijokardijaku.
myocardial ischaemia/myocardial infarction

iskemija mijokardijaka (g3/4: 1.7%)
myocardial ischemia (g3/4: 1.7%)

ventrikulari, + anġina, + iskemija mijokardijaka, bradikardja
ischaemia, bradycardia,

insuffiċjenza tal-qalb, infart mijokardijaku u iskemija mijokardijaka
cardiac failure, myocardial infarction and myocardial ischaemia

iskemija mijokardijaka/infart mijokardijaku li jseħħ waqt jew fi
myocardial ischaemia/myocardial infarction occurring during or

effetti diretti ta’ sufentanil fuq il-funzjoni mijokardijaka ma ġewx osservati.
direct effects of sufentanil on myocardial function were not observed.

attakk tal-qalb, uġigħ fis-sider (infart u iskemija mijokardijaka)
heart attack, chest pain (myocardial infarction and ischaemia)

iskemja mijokardijaka, arritmija, insuffiċjenza tal- qalb konġestiva), (ara sezzjoni 4. 8).
as with other antimuscarinics, fesoterodine should be used with caution in patients with risk for qt- prolongation (e. g. hypokalaemia, bradycardia and concomitant administration of medicines known to prolong qt interval) and relevant pre-existing cardiac diseases (e. g. myocardial ischaemia, arrhythmia, congestive heart failure), (see section 4.8).

arritmiji kardijaċi (fibrillazzjoni atrijali, ekstrasistoli ventrikulari, takiarritmija), iskemja mijokardijaka, kollass tal-qalb
cardiac arrhythmias (atrial fibrillation, ventricular extrasystoles, tachyarrhythmia), myocardial ischaemia, heart failure

tnaqqis jew twaqqif tad-doża għandhom jiġu kkunsidrati f’pazjenti li jiżviluppaw sinjali ta’ iskemija mijokardijaka jew ċerebrali.
dose reduction or discontinuation should be considered in a patient developing signs of myocardial or cerebral ischaemia.

infart mijokardijaku (li jinkludi dak akut)◊, fibrillazzjoni atrijali, insuffiċjenza kardijaka konġestiva, takikardija, insuffiċjenza kardijaka, iskemija mijokardijaka
myocardial infarction (including acute)^, atrial fibrillation, congestive cardiac failure, tachycardia, cardiac failure, myocardial ischaemia

ma ’ tulhom kollha, l - informazzjoni disponibbli fuq ir- riskju ta ’ iskemja mijokardijaka m’ hijiex konklussiva.
in their entirety, the available data on the risk of myocardial ischaemia are inconclusive.

timolol huwa mblokkatur adrinerġiku mhux selettiv li m’għandux attività simpatomimetika intrinsika, attività ta’ depressjoni mijokardijaka diretta jew attività ta’ stabilizzazzjoni tal-membrana.
timolol is a non-selective adrenergic blocking agent that has no intrinsic sympathomimetic, direct myocardial depressant or membrane-stabilising activity.